WATSON 335 (Acyclovir 400 mg)

Pill imprint WATSON 335 has been identified as Acyclovir 400 mg.

Acyclovir is used in the treatment of herpes simplex; herpes simplex, suppression; herpes zoster; herpes simplex, mucocutaneous/immunocompetent host; infectious mononucleosis (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 335

Acyclovir 400 mg WATSON 335
Acyclovir 400 mg WATSON 335
Acyclovir
Imprint:
WATSON 335
Strength:
400 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Purine nucleosides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0335
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4765 A S Medication Solutions LLC (repackager)
54868-3997 Physicians Total Care Inc (repackager)
55887-0246 Diversified Healthcare Services Inc (repackager)
13411-0182 Advanced Pharmaceutical Services Inc (repackager)
63874-0500 Altura Pharmaceuticals Inc (repackager)
53002-0008 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)